|
IN DEFENSE OF SMOKERS © 1996, Lauren A. Colby. Version 2.0 |
Addendum |
AddendumOctober 27, 1996
All of this panic was based upon a single article, published in Science magazine
under the title, "preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer
Mutational Hotspots in P53", and authored by Dennisenko, Pao and Tang. Apparently,
nobody read the original article with a critical eye because, if they had done so, it would
be apparent, to put it charitably, that the study described in the article is
underwhelming.
The authors of the article start out by pointing out that, in about 60% of lung
cancer cases, there is mutational damage to the p53 gene, the so-called "guardian angel
gene", which is thought by some to prevent cancer from developing. This is another way
of saying, of course, that in 40% of lung cancer cases, there is no damage to the gene,
meaning that people can get lung cancer even if their p53 genes are in perfect condition.
The authors did not study any actual human lung cancers. Rather, they studied
cultured human cells. They exposed these cells to a "metabolite" of benzo(a)pyrene (BAP),
benzo(a)pyrene diolepoxide (BAPDE). They then tested the cells for mutational damage,
and claim to have found mutations at certain locations on the genes, similar to the ones
found in 60% of lung cancer cases.
Before going any further, let's look at that word "metabolite". A metabolite is a
substance produced by the process of metabolism in the human body. Metabolisis takes
place in the gut and the liver, and the products of metabolisis flow into the bloodstream
where they reach the lungs, during the process of re-oxygenation. BAP is a ubiquitous
substance, produced by the combustion of vegetation and fossil fuels, and by burnt food.
Earlier studies have shown that better than 90% of the BAP consumed by humans, even
human smokers, comes from the food supply. The authors of the study apparently
concede that BAP, in and of itself is not terribly carcinogenic (although, like any
irritating substance, it will produce skin cancers in specially bred "nude mice"); it must
be converted to BAPDE. There is no evidence that the lungs, themselves, can metabolize
BAP into BAPDE. Even if they could, the amount of BAP reaching the lungs from
cigarette smoke is dwarfed by the amount reaching the lungs in the blood supply (and
already metabolized into BAPDE) from consumption of burnt food. Thus, at the outset,
the study appears flawed. However, it gets worse!
Not having any humans to work with, the authors of the study compared the
mutations which they had induced with specimens of DNA taken from a gene data base,
compiled by others. Now, if the goal of the study was to prove that BAP from smoking
causes lung cancer (and that was, indeed, the goal), it would seem to be scientifically
necessary to compare the genes of smokers who fall victim to lung cancer with those of
non-smokers who fall victim to the disease. Such a comparison would show whether lung
cancer in smokers has a different etiology (cause) than in non-smokers.
The authors of the study, however, deliberately excluded from the study any DNA
samples obtained from non-smokers or from "radon associated cancers". They did not
say how they knew whether any particular samples came from non-smokers or were
"radon associated"; apparently they took the word of the people who complied the data
base. The point is, however, that while all experiments should always be controlled,
these authors deliberately threw out the controls!
The authors make the astonishing statement that "This study provides a direct link
between a defined cigarette smoke carcinogen and human cancer mutations". I say
"astonishing", because the study dealt with BAPDE, not BAP, and there is no BAPDE in
cigarette smoke. Thus, at best, the study could claim only an "indirect link". But,
because the of the failure to take into account the BAP consumed in food, it isn't possible
to claim even an "indirect link". The study could just as well be said to prove an indirect
link between the consumption of burnt food and lung cancer. However, it doesn't prove
even that, because (a) it does not explain lung cancer in the 40% of victims who have no
p53 gene damage and (b) the authors compared their results with DNA samples which
they selectively picked and chose, throwing out which they deemed to be "radon
associated" or from non-smokers (free translation: throwing out those that would not
have validated their conclusions).
|